AB
STOK icon

Amalgamated Bank’s Stoke Therapeutics STOK Stock Holding History

Amalgamated Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,409
Closed -$45K – 2672
2025
Q4 		$45K Buy
1,409
+169
+14% +$5.08K ﹤0.01% 1862
2025
Q3 		$29K Hold
1,240
– – ﹤0.01% 1999
2025
Q2 		$14K Hold
1,240
– – ﹤0.01% 2285
2025
Q1 		$8K Buy
1,240
+261
+27% +$2.43K ﹤0.01% 2491
2024
Q4 		$11K Hold
979
– – ﹤0.01% 2403
2024
Q3 		$12K Hold
979
– – ﹤0.01% 2373
2024
Q2 		$13K Buy
979
+192
+24% +$2.59K ﹤0.01% 2323
2024
Q1 		$11K Sell
787
-1,312
-63% -$7.95K ﹤0.01% 2407
2023
Q4 		$11K Sell
2,099
-234
-10% -$1K ﹤0.01% 2848
2023
Q3 		$9K Hold
2,333
– – ﹤0.01% 2917
2023
Q2 		$25K Hold
2,333
– – ﹤0.01% 2633
2023
Q1 		$19K Sell
2,333
-520
-18% -$4.69K ﹤0.01% 2672
2022
Q4 		$26K Hold
2,853
– – ﹤0.01% 2680
2022
Q3 		$37K Hold
2,853
– – ﹤0.01% 2586
2022
Q2 		$38K Sell
2,853
-265
-8% -$4.03K ﹤0.01% 2615
2022
Q1 		$66K Buy
+3,118
New +$62.4K ﹤0.01% 2336

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Amalgamated Bank's STOK Position: Q1 2026 in Review

Amalgamated Bank sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 1,409 shares — an estimated $45K sold.

Amalgamated Bank first reported a position in STOK in Q1 2022 and held it in 16 quarters. The position peaked at $66K in Q1 2022. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Amalgamated Bank reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,409 Stoke Therapeutics shares in Q1 2026, an estimated $45K.
  • Amalgamated Bank first reported a position in Stoke Therapeutics in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Stoke Therapeutics position peaked at $66K in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.